Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The NIH website-transition announcement banner was removed from the top of the page.
    Difference
    1%
    Check dated 2026-11-09T00:14:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T00:12:11.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T23:53:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-19T00:28:32.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T00:12:17.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the study details and navigation with an access-denied notice. This indicates restricted access rather than an update to the study data.
    Difference
    17%
    Check dated 2026-09-20T22:56:58.000Z thumbnail image

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.